Nanotechnology is an engineered solution that addresses several overlapping issues. These include bacterial colonization of the implant, inflammation around the implant, vascularization after implantation, and osseointegration. Solutions optimized for one of these problems may not solve others. We focused on innovating nanotechnology to address all four issues in a single approach.
Nanovis' nanotechnology increases protein attachment for a lower immune response. It also decreases inflammatory cell attachment and activation while encouraging pro-healing macrophages.
Nanovis implants incorporate antimicrobial elements to reduce the risk of infections, a major concern in orthopedic and spinal surgeries.
Our nanotubes speed up vascular growth on the implant, supporting new bone growth and accelerating healing.
Osseointegration is the marker of successful implantation. The sooner bone firmly attaches to the implant, the better the outcome.
Focused on our four pillars of healing, Nanovis engineers and produces nano surface technologies to improve the integration of orthopedic, spinal, and dental implants.
Nanovis® maintains a robust intellectual property portfolio consisting of several owned or licensed patents. All nanoVIS Ti™ Surface Technology components are protected by a series of patents. Additionally, the proprietary process used to produce our unique surface is safeguarded by multiple trade secrets.
NanoVIS Ti™ Surface Technology is the only widely available platform nanotechnology to achieve FDA’s nanotechnology designation.
We are the first company worldwide to obtain FDA clearance and nanotechnology designation for a pedicle screw system.
We are the second company worldwide to receive FDA clearance and nanotechnology designation for an interbody fusion cage.
The Master File for nanoVIS Ti™ Surface Technology has been referenced for multiple 510k clearances across two different product types in spine.
The application of nanoVIS Ti™ Surface Technology utilizes a validated manufacturing process that can fit within any supply chain. The flexibility of our proprietary process allows for the support of a wide range of quantities, both large and small, in an economical way.
To validate the nanoVIS Ti™ Surface Technology, Nanovis® has commercialized a portfolio of spinal products.
FDA nanotechnology designation. First company in the world with designation on Peek + Ti Interbodies (CP Ti), and Open and MIS pedicle screws (ELI Ti).
Statistically significant and superior comparative surface data in the label – hMSC mineralization and osteoblast mineralization at 21 days, in vitro.
On-label marketing for superior positioning and messaging.
Superior FDA label used to drive new surgeon conversions, hospital approvals, and technology price premiums.
Surface on a surface story. Great way to further enhance/differentiate with a nano surface on a macro-porous 3D printed surface, or a micron roughened surface.
Surgeon engagement at a scientific and innovation level creating opportunities for studies, papers, podium presentations, etc.
